P53 Gene Mutation Identified by Next Generation Sequencing in Poorly Differentiated Neuroendocrine Carcinoma of the Nasal Cavity

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Head and Neck Pathology

• Publication date

  2018-05-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12105-018-0934-2PMID 29845478PMCID PMC6684699
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• WHO classification of head and neck tumours

  2017cited by this paper
• Whole-genome landscape of pancreatic neuroendocrine tumours

  2017cited by this paper
• COSMIC: somatic cancer genetics at high-resolution

  2016cited by this paper
• Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsets

  2016cited by this paper
• Primary Combined Neuroendocrine and Squamous Cell Carcinoma of the Maxillary Sinus: Report of a Case with Immunohistochemical and Molecular Characterization

  2015cited by this paper
• Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.

  2015cited by this paper
• WHO classification of tumours of the lung, pleura, thymus and heart

  2015cited by this paper
• The Comparative Pathology of Genetically Engineered Mouse Models for Neuroendocrine Carcinomas of the Lung

  2015cited by this paper
• Molecular characteristics of colorectal neuroendocrine carcinoma; similarities with adenocarcinoma rather than neuroendocrine tumor.

  2015cited by this paper
• p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma

  2014cited by this paper
• p53 suppresses carcinoma progression by inhibiting mTOR pathway activation

  2014cited by this paper
• Conditional deletion of p53 and Rb in the renin-expressing compartment of the pancreas leads to a highly penetrant metastatic pancreatic neuroendocrine carcinoma

  2014cited by this paper
• Frequent mutations in chromatin-remodeling genes in pulmonary carcinoids

  2014cited by this paper
• An exploration of pathways involved in lung carcinoid progression using gene expression profiling.

  2013cited by this paper
• Large cell neuroendocrine carcinoma presenting with neck swelling in the submandibular gland: a case report

  2013cited by this paper
• A Genomics-Based Classification of Human Lung Tumors

  2013cited by this paper
• Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma

  2013cited by this paper
• Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer

  2013cited by this paper
• Head and Neck Large Cell Neuroendocrine Carcinoma Should Be Separated From Atypical Carcinoid On the Basis of Different Clinical Features, Overall Survival, and Pathogenesis

  2012cited by this paper
• Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.

  2012cited by this paper
• Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors

  2012cited by this paper
• Large cell neuroendocrine carcinoma of the head and neck.

  2012cited by this paper
• Mucosal large cell neuroendocrine carcinoma of the head and neck regions in Japanese patients: a distinct clinicopathological entity

  2012cited by this paper
• New plays in the p53 theater.

  2011cited by this paper
• Deletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcome.

  2011cited by this paper
• Large Cell Neuroendocrine Carcinoma of the Larynx: Definition of an Entity

  2010cited by this paper
• The first 30 years of p53: growing ever more complex

  2009cited by this paper
• Non-Small Cell Neuroendocrine Carcinoma of the Sinonasal Tract and Nasopharynx. Report of 2 Cases and Review of the Literature

  2007cited by this paper
• Carcinoid tumours of the larynx

  2005cited by this paper
• Large cell neuroendocrine carcinoma of the parotid gland: case report and literature review.

  2005cited by this paper
• Primary Large-Cell Neuroendocrine Carcinoma of the Parotid Gland: Immunohistochemical and Molecular Analysis of Two Cases

  2000cited by this paper
• Molecular changes in the bronchial epithelium of patients with small cell lung cancer.

  2000cited by this paper
• The p53/p63/p73 family of transcription factors: overlapping and distinct functions.

  2000cited by this paper
• Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.

  1996cited by this paper
• Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

  1994cited by this paper
• Tumor suppressor p53: analysis of wild-type and mutant p53 complexes

  1991cited by this paper
• p53: a frequent target for genetic abnormalities in lung cancer.

  1989cited by this paper
• Moderately differentiated neuroendocrine carcinoma of the larynx: A clinicopathologic study of 54 cases

  1988cited by this paper
• Carcinoid tumour of the larynx

  1983cited by this paper

• Extrapulmonary poorly differentiated NECs, including molecular and immune aspects.

  2020cites this paper